Mitochondrial response to controlled nutrition in health and disease

Nutrition Reviews

Volumn 69, Issue 2, 2011, Pages 65-75

  Schiff, Manuel ^a   Bénit, Paule ^b   Coulibaly, Assetou ^b   Loublier, Sandrine ^b   El Khoury, Riyad ^b   Rustin, Pierre ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Aging; Ketogenic diet; Mitochondria; Mitochondrial diseases; Nutrition; Oxidative phosphorylation

Indexed keywords

ACETYLCYSTEINE; AMYLOID BETA PROTEIN; ARGININE; ASCORBIC ACID; CARNITINE; CREATINE; FLAVOPROTEIN; MENADIOL SODIUM PHOSPHATE; METHIONINE; MITOCHONDRIAL DNA; NICOTINAMIDE; NUTRACEUTICAL; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; SIRTUIN 1; SUCCINIC ACID; THIAMINE; UBIDECARENONE; UNCOUPLING PROTEIN 2;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOGENESIS; CALORIC INTAKE; CALORIC RESTRICTION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DROSOPHILA; EDITORIAL; ELECTRON TRANSPORT; FATTY ACID OXIDATION; HUMAN; INSULIN RESISTANCE; LACTIC ACIDOSIS; LIFESPAN; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN RESTRICTION; RESPIRATORY CHAIN; SKELETAL MUSCLE; STROKE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 79551631857     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00363.x     Document Type: Editorial

References (125)

1. Tzagoloff A. Mitochondria. New York: Plenum Press; 1982.
2. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298-300.
3. Trifunovic A, Wredenberg A, Falkenberg M, etal. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429:417-423.
4. Trifunovic A, Hansson A, Wredenberg A, etal. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA. 2005;102:17993-17998.
5. Hiona A, Sanz A, Kujoth GC, etal. Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS ONE. 2010;5:e11468.
6. Van Remmen H, Ikeno Y, Hamilton M, etal. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics. 2003;16:29-37.
7. Dufour E, Boulay J, Rincheval V, Sainsard-Chanet A. A causal link between respiration and senescence in Podospora anserina. Proc Natl Acad Sci USA. 2000;97:4138-4143.
8. Rea SL, Ventura N, Johnson TE. Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol. 2007;5:e259.
9. Walker G, Houthoofd K, Vanfleteren JR, Gems D. Dietary restriction in C. elegans: from rate-of-living effects to nutrient sensing pathways. Mech Ageing Dev. 2005;126:929-937.
10. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr. 1935;10:63-79.
11. Colman RJ, Anderson RM, Johnson SC, etal. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325:201-204.
12. Fontana L, Partridge L, Longo VD. Extending healthy life span - from yeast to humans. Science. 2010;328:321-326.
13. Gredilla R, Sanz A, Lopez-Torres M, Barja G. Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. Faseb J. 2001;15:1589-1591.
14. Lin SJ, Kaeberlein M, Andalis AA, etal. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature. 2002;418:344-348.
15. Bishop NA, Guarente L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature. 2007;447:545-549.
16. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289:2126-2128.
17. Bamps S, Wirtz J, Savory FR, Lake D, Hope IA. The Caenorhabditis elegans sirtuin gene, sir-2.1, is widely expressed and induced upon caloric restriction. Mech Ageing Dev. 2009;130:762-770.
18. Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci USA. 2004;101:15998-16003.
19. Cohen HY, Miller C, Bitterman KJ, etal. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305:390-392.
20. Nisoli E, Tonello C, Cardile A, etal. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science. 2005;310:314-317.
21. Lin SJ, Ford E, Haigis M, Liszt G, Guarente L. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 2004;18:12-16.
22. Yang H, Yang T, Baur JA, etal. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell. 2007;130:1095-1107.
23. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005;1:361-370.
24. Imai S, Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci. 2010;31:212-220.
25. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434:113-118.
26. Chen D, Bruno J, Easlon E, etal. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008;22:1753-1757.
27. Bordone L, Motta MC, Picard F, etal. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 2006;4:e31.
28. Qin W, Yang T, Ho L, etal. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem. 2006;281:21745-21754.
29. Prozorovski T, Schulze-Topphoff U, Glumm R, etal. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol. 2008;10:385-394.
30. Ramadori G, Lee CE, Bookout AL, etal. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci. 2008;28:9989-9996.
31. Civitarese AE, Carling S, Heilbronn LK, etal. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007;4:e76.
32. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA. 2009;106:20405-20410.
33. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416:15-18.
34. Duval C, Negre-Salvayre A, Dogilo A, Salvayre R, Penicaud L, Casteilla L. Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol. 2002;80:757-764.
35. Samec S, Seydoux J, Dulloo AG. Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB J. 1998;12:715-724.
36. Harper ME, Dent R, Monemdjou S, etal. Decreased mitochondrial proton leak and reduced expression of uncoupling protein 3 in skeletal muscle of obese diet-resistant women. Diabetes. 2002;51:2459-2466.
37. Toime LJ, Brand MD. Uncoupling protein-3 lowers reactive oxygen species production in isolated mitochondria. Free Radic Biol Med. 2010;49(4):606-611.
38. Trifunovic A, Larsson NG. Mitochondrial dysfunction as a cause of ageing. J Intern Med. 2008;263:167-178.
39. Morselli E, Maiuri MC, Markaki M, etal. The life span-prolonging effect of sirtuin-1 is mediated by autophagy. Autophagy. 2010;6:186-188.
40. Hirschey MD, Shimazu T, Goetzman E, etal. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010;464:121-125.
41. Sanz A, Caro P, Sanchez JG, Barja G. Effect of lipid restriction on mitochondrial free radical production and oxidative DNA damage. Ann N Y Acad Sci. 2006;1067:200-209.
42. Sanz A, Gomez J, Caro P, Barja G. Carbohydrate restriction does not change mitochondrial free radical generation and oxidative DNA damage. J Bioenerg Biomembr. 2006;38:327-333.
43. Grandison RC, Piper MD, Partridge L. Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila. Nature. 2009;462:1061-1064.
44. Pamplona R, Barja G. Mitochondrial oxidative stress, aging and caloric restriction: the protein and methionine connection. Biochim Biophys Acta. 2006;1757:496-508.
45. Lopez-Torres M, Barja G. Lowered methionine ingestion as responsible for the decrease in rodent mitochondrial oxidative stress in protein and dietary restriction possible implications for humans. Biochim Biophys Acta. 2008;1780:1337-1347.
46. Sanz A, Caro P, Barja G. Protein restriction without strong caloric restriction decreases mitochondrial oxygen radical production and oxidative DNA damage in rat liver. J Bioenerg Biomembr. 2004;36:545-552.
47. Sanz A, Caro P, Ayala V, Portero-Otin M, Pamplona R, Barja G. Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins. FASEB J. 2006;20:1064-1073.
48. Gomez J, Caro P, Naudi A, Portero-Otin M, Pamplona R, Barja G. Effect of 8.5% and 25% caloric restriction on mitochondrial free radical production and oxidative stress in rat liver. Biogerontology. 2007;8:555-566.
49. Garlick PJ. Toxicity of methionine in humans. J Nutr. 2006;136(Suppl 6):S1722-S1725.
50. Baric I. Inherited disorders in the conversion of methionine to homocysteine. J Inherit Metab Dis. 2009;32:459-471.
51. Zeviani M, Carelli V. Mitochondrial disorders. Curr Opin Neurol. 2007;20:564-571.
52. Roef MJ, Reijngoud DJ, Jeneson JA, Berger R, de Meer K. Resting oxygen consumption and in vivo ADP are increased in myopathy due to complex I deficiency. Neurology. 2002;58:1088-1093.
53. Pospisilik JA, Knauf C, Joza N, etal. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell. 2007;131:476-491.
54. Wortmann SB, Zweers-van Essen H, Rodenburg RJ, etal. Mitochondrial energy production correlates with the age-related BMI. Pediatr Res. 2009;65:103-108.
55. Morava E, Rodenburg R, van Essen HZ, De Vries M, Smeitink J. Dietary intervention and oxidative phosphorylation capacity. J Inherit Metab Dis. 2006;29:589.
56. Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol. 2010;5:297-348.
57. Roef MJ, de Meer K, Reijngoud DJ, etal. Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to complex I deficiency. Am J Clin Nutr. 2002;75:237-244.
58. Kliewer SA, Sundseth SS, Jones SA, etal. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA. 1997;94:4318-4323.
59. Hancock CR, Han DH, Chen M, etal. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A. 2008;105:7815-7820.
60. Kossoff EH, Rho JM. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics. 2009;6:406-414.
61. Kang HC, Lee YM, Kim HD, Lee JS, Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia. 2007;48:82-88.
62. Joshi CN, Greenberg CR, Mhanni AA, Salman MS. Ketogenic diet in Alpers-Huttenlocher syndrome. Pediatr Neurol. 2009;40:314-316.
63. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. Ketone bodies, potential therapeutic uses. IUBMB Life. 2001;51:241-247.
64. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009;59:293-315.
65. Bough KJ, Wetherington J, Hassel B, etal. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60:223-235.
66. Masino SA, Geiger JD. Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci. 2008;31:273-278.
67. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007;145:256-264.
68. Santra S, Gilkerson RW, Davidson M, Schon EA. Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann Neurol. 2004;56:662-669.
69. Cullingford TE, Dolphin CT, Sato H. The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacology. 2002;42:724-730.
70. Cullingford TE, Eagles DA, Sato H. The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 2002;49:99-107.
71. Fraser DD, Whiting S, Andrew RD, Macdonald EA, Musa-Veloso K, Cunnane SC. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology. 2003;60:1026-1029.
72. Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N. Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry. 1999;38:185-190.
73. Ahola-Erkkila S, Carroll CJ, Peltola-Mjosund K, etal. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet. 2010;19:1974-1984.
74. Srivastava S, Diaz F, Iommarini L, Aure K, Lombes A, Moraes CT. PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum Mol Genet. 2009;18:1805-1812.
75. Wenz T, Diaz F, Spiegelman BM, Moraes CT. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 2008;8:249-256.
76. Bastin J, Aubey F, Rotig A, Munnich A, Djouadi F. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J Clin Endocrinol Metab. 2008;93:1433-1441.
77. Rotig A, Appelkvist EL, Geromel V, etal. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet. 2000;356:391-395.
78. Marriage BJ, Clandinin MT, Macdonald IM, Glerum DM. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol Genet Metab. 2004;81:263-272.
79. Kerr DS. Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Mol Genet Metab. 2009;99:246-255.
80. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet. 1999;354:477-479.
81. Rotig A, de Lonlay P, Chretien D, etal. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17:215-217.
82. Di Prospero NA, Baker A, Jeffries N, Fischbeck KH. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 2007;6:878-886.
83. Sumien N, Heinrich KR, Shetty RA, Sohal RS, Forster MJ. Prolonged intake of coenzyme Q10 impairs cognitive functions in mice. J Nutr. 2009;139:1926-1932.
84. Eleff S, Kennaway NG, Buist NR, etal. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA. 1984;81:3529-3533.
85. Andreu AL, Hanna MG, Reichmann H, etal. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med. 1999;341:1037-1044.
86. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997;20:1502-1509.
87. Klopstock T, Querner V, Schmidt F, etal. A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology. 2000;55:1748-1751.
88. Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007;35:235-242.
89. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988;319:1331-1336.
90. Infante JP, Huszagh VA. Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: a common denominator in the pathophysiology of diseases of oxidative phosphorylation and beta-oxidation. FEBS Lett. 2000;468:1-5.
91. Hsu CC, Chuang YH, Tsai JL, etal. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol Scand. 1995;92:252-255.
92. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol. 1987;74:226-233.
93. Koga Y, Akita Y, Nishioka J, etal. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology. 2005;64:710-712.
94. Kubota M, Sakakihara Y, Mori M, Yamagata T, Momoi-Yoshida M. Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain Dev. 2004;26:481-483.
95. Dassa EP, Dufour E, Goncalves S, etal. Expressing the alternative oxidase complements cytochrome c oxidase deficiency in human cells. EMBO Mol Med. 2009;1:30-36.
96. Passarelli C, Tozzi G, Pastore A, Bertini E, Piemonte F. GSSG-mediated complex I defect in isolated cardiac mitochondria. Int J Mol Med. 2010;26:95-99.
97. Acin-Perez R, Hoyos B, Zhao F, etal. Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J. 2010;24:627-636.
98. Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst Rev. 2006;(1):CD004426.
99. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664-671.
100. Szendroedi J, Schmid AI, Chmelik M, etal. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med. 2007;4:e154.
101. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944-2950.
102. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005;54:8-14.
103. Morino K, Petersen KF, Dufour S, etal. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 2005;115:3587-3593.
104. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia. 2007;50:790-796.
105. Mogensen M, Sahlin K, Fernstrom M, etal. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes. 2007;56:1592-1599.
106. Schrauwen-Hinderling VB, Roden M, Kooi ME, Hesselink MK, Schrauwen P. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Curr Opin Clin Nutr Metab Care. 2007;10:698-703.
107. Holloszy JO. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr. 2009;89(Suppl):S463-S466.
108. Hammer S, Snel M, Lamb HJ, etal. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008;52:1006-1012.
109. Toledo FG, Menshikova EV, Ritov VB, etal. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes. 2007;56:2142-2147.
110. Lane MA, Ingram DK, Roth GS. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicol Sci. 1999;52(Suppl 2):41-48.
111. Baur JA, Pearson KJ, Price NL, etal. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
112. Lagouge M, Argmann C, Gerhart-Hines Z, etal. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109-1122.
113. Ramadori G, Gautron L, Fujikawa T, Vianna CR, Elmquist JK, Coppari R. Central administration of resveratrol improves diet-induced diabetes. Endocrinology. 2009;150:5326-5333.
114. Banks AS, Kon N, Knight C, etal. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 2008;8:333-341.
115. De Feyter HM, Lenaers E, Houten SM, etal. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. FASEB J. 2008;22:3947-3955.
116. De Feyter HM, van den Broek NM, Praet SF, Nicolay K, van Loon LJ, Prompers JJ. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur J Endocrinol. 2008;158:643-653.
117. Hoeks J, Briede JJ, de Vogel J, etal. Mitochondrial function, content and ROS production in rat skeletal muscle: effect of high-fat feeding. FEBS Lett. 2008;582:510-516.
118. Wredenberg A, Freyer C, Sandstrom ME, etal. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun. 2006;350:202-207.
119. Atamna H, Frey WH 2nd. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion. 2007;7:297-310.
120. Morais VA, Verstreken P, Roethig A, etal. Parkinson's disease mutations in PINK1 result in decreased complex I activity and deficient synaptic function. EMBO Mol Med. 2009;1:99-111.
121. Maswood N, Young J, Tilmont E, etal. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci U S A. 2004;101:18171-18176.
122. Wang J, Ho L, Qin W, etal. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alz-heimer's disease. FASEB J. 2005;19:659-661.
123. Mouton PR, Chachich ME, Quigley C, Spangler E, Ingram DK. Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice. Neurosci Lett. 2009;464:184-187.
124. Kim D, Nguyen MD, Dobbin MM, etal. SIRT1 deacetylase protects against neurodegeneration in models for Alz-heimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007;26:3169-3179.
125. Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol. 2007;73:550-560.